Regis Technologies Expands Applications for Its Chiral Columns

Regis Technologies Expands Applications for Its Chiral Columns

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
Polysaccharide and Pirkle-type Columns Proved Useful for Numerous Methods 

Morton Grove, Illinois -- February 23, 2010. Regis Technologies, Inc., a leader in chiral separations serving the analytical and preparative needs of chromatographers worldwide, developed numerous applications for its RegisCell®,  RegisPack® and Whelk-O®1 chiral columns, proving they are a viable solution for many chiral separation problems.

The Regis Chiral Screening Laboratory demonstrated the applicability of polysaccharide and Pirkle-type columns in numerous methods and recent beta testing by large pharmaceutical organizations yielded excellent evaluation when compared to other cellulose- and amylose-based columns.

Regis offers free chiral screening of samples using its RegisCell and RegisPack polysaccharide columns, Whelk-O1 Pirkle-type column and ChiroSil® Crown-Ether columns. The complimentary screening, which involves a number of additional chiral phases more specific in selectivity, enables scientists to determine the appropriate column for a specific application, as well as to compare results using Regis columns with results using other columns.

Regis columns, available in phases from analytical to bulk, offer an affordable choice for quality columns that deliver superior separations and excellent selectivity. All Regis chiral columns are available at the same cost for both SFC and HPLC analyses.

Regis Technologies also offers SFC Separation Services.  As a manufacturer of chiral stationary phases, Regis solves separation problems at a lower cost with valuable chiral expertise in method development and scale up.
 
Learn more about Regis Technologies' comprehensive range of affordable, quality columns, and separations services, at Booth 2212 during Pittcon, February 28 -- March 4 in Orlando, or on the Web at http://www.registech.com.

About Regis Technologies, Inc.
Regis Technologies is an FDA-inspected, cGMP-compliant API manufacturer with over 50 years of experience in custom synthesis and chromatography products. Regis manufactures a comprehensive line of chiral HPLC and SFC columns and packings, specialty HPLC columns, high-purity ion-pairing reagents, GC derivatization reagents, and performs Preparative SFC Separations. Regis has been a leader in chiral chromatography since the 1980s. For more information, visit www.registech.com.
 

Contacts:
Jelena Kocergin
Business Development Manager, Chromatography Products
847-583-7649
[email protected]

Debra Harrsch
Brandwidth Solutions LLC
215-997-8575
[email protected]

Suggested Articles

After delivering a "positive surprise" in December, Biogen is painting a fuller picture of its lupus drug.

A new CRISPR technique neutralizes SARS-CoV-2 by scrambling the virus' genetic code. It could prove useful for fighting other viruses, like influenza.

The deal, which follows a bidding war with AcelRx, gives Melinta another approved antibiotic and potentially complementary R&D expertise.